The Successful Synchronized Orchestration of an Investigator-Initiated Multicenter Trial Using a Clinical Trial Management System and Team Approach: Design and Utility Study (Preprint)
Preprint
- 11 May 2021
- preprint
- Published by JMIR Publications Inc. in JMIR Preprints
Abstract
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author). Background: As the cost of clinical trials continues to rise, novel approaches are required to ensure ethical allocation of resources. Multisite trials have been increasingly utilized in phase 1 trials for rare diseases and in phase 2 and 3 trials to meet accrual needs. The benefits of multisite trials include easier patient recruitment, expanded generalizability, and more robust statistical analyses. However, there are several problems more likely to arise in multisite trials, including accrual inequality, protocol nonadherence, data entry mistakes, and data integration difficulties. Objective: The Biostatistics & Data Science department at the University of Kansas Medical Center developed a clinical trial management system (comprehensive research information system [CRIS]) specifically designed to streamline multisite clinical trial management. Methods: A National Institute of Child Health and Human Development–funded phase 3 trial, the ADORE (assessment of docosahexaenoic acid [DHA] on reducing early preterm birth) trial fully utilized CRIS to provide automated accrual reports, centralize data capture, automate trial completion reports, and streamline data harmonization. Results: Using the ADORE trial as an example, we describe the utility of CRIS in database design, regulatory compliance, training standardization, study management, and automated reporting. Our goal is to continue to build a CRIS through use in subsequent multisite trials. Reports generated to suit the needs of future studies will be available as templates. Conclusions: The implementation of similar tools and systems could provide significant cost-saving and operational benefit to multisite trials. Trial Registration: ClinicalTrials.gov NCT02626299; https://tinyurl.com/j6erphcjKeywords
All Related Versions
- Published version: JMIR Formative Research, 5 (12), e30368.
This publication has 17 references indexed in Scilit:
- Assessment of DHA on reducing early preterm birth: the ADORE randomized controlled trial protocolBMC Pregnancy and Childbirth, 2017
- A Bayesian comparative effectiveness trial in action: developing a platform for multisite study adaptive randomizationTrials, 2016
- Many multicenter trials had few events per center, requiring analysis via random-effects models or GEEsJournal of Clinical Epidemiology, 2015
- Research staff training in a multisite randomized clinical trial: Methods and recommendations from the stimulant reduction intervention using dosed exercise (STRIDE) trialAddiction Research & Theory, 2013
- Comparison of Electronic Data Capture (EDC) with the Standard Data Capture Method for Clinical Trial DataPLOS ONE, 2011
- Rapidly rising clinical trial costs worry researchersCanadian Medical Association Journal, 2009
- Sources of site differences in the efficacy of a multisite clinical trial: The treatment of SSRI-resistant depression in adolescents.Journal of Consulting and Clinical Psychology, 2009
- Implementation of electronic data capture systems: Barriers and solutionsContemporary Clinical Trials, 2007
- The Gini coefficient as a measure for understanding accrual inequalities in multicenter clinical studiesJournal of Clinical Epidemiology, 2004
- Vorteile und Probleme multizentrischer Therapiestudien am Beispiel einer Studie zur Behandlung des metastasierenden Nierenzellkarzinoms mit rekombinantem Interferon-Alpha-2COncology Research and Treatment, 1987